{"disease":{"id":"efficacy-and-safty-of-camrelizumab-plus-s-1-maintenance-after-first-line-induction-chemotherapy-for-gc","name":"efficacy and safty of camrelizumab plus s 1 maintenance after first line induction chemotherapy for gc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05170542","title":"The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma.","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":42,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}